INNOVATION FUNDING

Syreon Research Institute is deeply engaged in supporting healthcare innovation networks. Through our Innovation Funding services, we combine extensive scientific expertise in medicine and health economics with business strategy and corporate finance capabilities. We aim to support healthcare innovators at both early and later stages of development, as well as investors seeking to identify, assess, and execute the most promising investment opportunities.

Our Innovation Funding team brings together professionals with backgrounds in fundraising, corporate finance, M&A and strategy consulting, supported by Syreon’s full research and expert network. The service offering is largely built on Syreon’s early health technology assessment (eHTA) methodology, which helps to evaluate the value-based potential of early-phase healthcare innovations.

Based on this toolkit, we provide support to stand-alone innovators, as well as to investors considering investments in healthcare companies or managing existing portfolio companies.

In the last 5 years, we supported 110+ start-ups from 10+ countries and in 15+ indications.

SYREON RESEARCH INSTITUTE OFFERS

For Innovators
  • Initial idea or business concept assessment based on our standardized early Health Technology Assessment methodology
  • Market sizing and business modelling based on evidence synthesis
  • Fundraising, corporate finance, M&A and transaction preparation
For Investors
  • Investment thesis validation: complex, healthcare-specific due diligence based on our HTA, fundraising, corporate finance, M&A and strategy consulting experience, tailored to individual investments
  • Market research, including KOL interviews and needs assessment
  • Support in matchmaking and deal execution
Post-investment services
  • Monitoring and/or coaching of portfolio companies
  • Recommendations for strategic realignment
  • Pricing and market access strategies
  • Global value dossiers
  • Assessment of potential new indications
  • Portfolio reviews
  • Exit preparation for both underperforming and well-performing investments